Академический Документы
Профессиональный Документы
Культура Документы
COLLEGE OF NURSING
VALENZUELA CAMPUS
Presented to:
Mr. Francis M. Culala
Presented by:
Bungay, Maria Paula M.
BSN 4Y 1-1
Group 1B
August 1, 201
TABLE OF CONTENTS
I. Introduction
II. Objectives
III. Patients Profile
IV. Anatomy and Physiology
V. Pathophysiology
VI. Laboratory Examination Results
VII. Gordons Assessment
VIII. Nursing Care Plans
IX. Drug Study
X. Health Teachings
I. Introduction
The pineal gland, which is a tiny gland located in the back of the base of the
brain, creates the neurotransmitters melatonin and serotonin, although its purpose is
not entirely clear. Tumors in this region can be of a wide variety of types; the most
common are germ cell tumors, which arise from developmental abnormalities, and
pineal cell tumors, which come from the cells of the pineal gland itself.
Regardless of the type of tumor involved, tumors in the pineal region usually
cause symptoms through one of three mechanisms. They can increase pressure in
the skull by blocking the flow of cerebrospinal fluid (hydrocephalus), they can
compress part of the brain, or they can cause disruptions in the endocrine system,
the system that controls hormones and includes the pineal gland. Hydrocephalus is a
common result of tumors in this region, and will lead first to headaches, and then
perhaps to nausea, vomiting, and altered mental status. The brainstem and the
cerebellum are the most common sites of compression from a pineal region tumor;
compression in these regions can cause abnormal eye movements (including
Parinauds syndrome, the inability to look up), double vision, uncoordinated body
movements, or unsteady gait. Endocrine dysfunction is less common and usually is
caused when the tumor involves the hypothalamus, a nearby brain region that is
involved in growth and metabolism.
The first line of treatment for pineal region tumors is surgery. The extent of
the surgical removal is a significant factor in outcome. In addition, the surgical
removal of the tumor will provide tissue samples, which are analyzed under a
microscope to provide an accurate diagnosis. If hydrocephalus is present, a shunt (a
tube that allows cerebrospinal fluid to flow out) may be placed prior to surgery. In the
case of benign tumors, complete resection usually provides a cure. For malignant
tumors, the removal of as much of the tumor as possible is thought to improve
outcome and response to adjuvant therapy. Some germ cell tumors respond very well
to radiation therapy, and chemotherapy may have a role in the treatment of some
tumor types. Stereotactic radiosurgery, which involves the use of a highly focused
beam of radiation to target the cancer cells and leave the surrounding brain
unaffected, also may be used in the case of small tumors.
Germ Cell Tumors
Intracranial germ cells tumors constitute a wide range of tumors that arise
from germ cells, including sex cells, present during the development process. Germ
cell tumors commonly are associated with the reproductive system, but there are
several types that occur in and around the brain.
Benign germ cell tumors include teratomas, dermoid tumors, and epidermoid
tumors. Endodermal sinus tumors, embryonal cell tumors, and choriocarcinomas are
at the malignant end of the spectrum, while germinomas and immature teratomas
fall somewhere in between. The pineal region is one of two areas in the brain where
germ cell tumors can occur. Germ cell tumors are very rare; they make up 0.4 to 3.4
percent of all intracranial tumors. In general, these tumors manifest in patients by
adolescence.
Germ cells tumors may arise from different types of cells, and they are
differentiated by biochemical markers in the blood and cerebrospinal fluid. Lab tests
for these markers will be used in addition to imaging tests (MRI and CT) and biopsies
to provide a diagnosis.
Treatment for germ cells tumors vary based on the tumor type and usually
consists of some combination of surgery, radiation therapy, and chemotherapy. In the
case of benign tumors, for example, complete surgical resection usually provides a
cure. Malignant germ cell tumors, on the other hand, require some kind of adjuvant
therapy. Germinomas, for example, are particularly sensitive to radiation therapy.
Germinomas and other malignant germ cell tumors also respond to chemotherapy as
an adjuvant treatment.
Pineal Cell Tumors
Unlike germ cell tumors, which arise in the pineal region despite being
unrelated to the pineal gland itself, pineal cells tumors arise directly from the
functional cells of the gland, called pineal parenchymal cells. These cells are
unrelated to the neurons and glial cells (supporting cells) in the brain. However, there
are glial cells present in the gland, and these cells may give rise to tumors called
gliomas.
Tumors that arise from pineal parenchymal cells are categorized according to
their malignancy. Pineocytomas are the more benign version, while pineoblastomas
are malignant. Even rarer than germ cell tumors, they make up just 0.4 to 1.0
percent of intracranial tumors. Approximately 50 percent of these are the malignant
pineoblastomas, 30 percent are pineocytomas, and 20 percent are mixed. These
tumors tend to occur from adolescence through middle age.
As with other brain tumors, imaging tests and surgical biopsy are used to
provide diagnosis and assess the malignancy of these tumors.
Surgery usually is the initial treatment. Complete surgical resection of discrete
benign pineocytomas is associated with an excellent prognosis and perhaps a cure.
For the more malignant pineoblastomas, surgical removal of as much of the tumor as
possible may improve the response to other forms of therapy. Radiation therapy has
shown some efficacy in treating pineoblastomas, but the role of chemotherapy is
unclear because it has not been studied extensively.
Masses in the pineal region have a relatively broad differential because of the
variety of cell types found in the region.
If large enough, the mass may compress the tectal plate which may cause a
defect in up-gaze (Parinaud syndrome) or, obstructive hydrocephalus if the cerebral
aqueduct is compressed.
Hydrocephalus
Is the buildup of too much cerebrospinal fluid in the brain. Normally, this fluid
cushions your brain. When you have too much, though, it puts harmful pressure on
your brain. Hydrocephalus can be congenital, or present at birth. Causes include
genetic problems and problems with how the fetus develops. An unusually large head
is the main sign of congenital hydrocephalus. Hydrocephalus can also happen after
birth. This is called acquired hydrocephalus. It can occur at any age. Causes can
Objectives:
Nurse Centered
1.
Describe factually, the personal and pertinent family history of the patient and
relate it to the present condition.
2. Perform comprehensive physical assessment.
3. Trace the book-based and client-centered pathophysiology
4. Determine the predisposing and precipitating factors and the signs and
symptoms and relate to the disease process.
5. Enumerate and describe the diagnostic and laboratory procedures as well as the
nursing responsibilities in relation to the disease condition
6. Enumerate the different treatment modalities and their indication specifically for
the patients condition.
7. Identify the pharmacologic treatment provided to the patient, relate the actions
of each drug with the disease process and evaluate the patients response to the
medications given.
8. Identify nursing diagnoses, formulate short-term goals, carry out appropriate
interventions and evaluate the plan.
9. Appraise the effectiveness of medical and surgical nursing management in
treating the patient.
10. List the preventive measure for the occurrence of Pineal region tumor.
Patient Centered
1. Report understanding of the disease process.
RR: 18cpm
SAO2: 97%
GENERAL SURVEY
Mr. ARD, Assessed/received patient lying on bed, sleeping, conscious with GCS
15. With the following vital signs:
Temperature: 36.7 C
Heart rate: 70 bpm
Respiratory rate: 20 bpm
Blood Pressure: 140/90 mmHg
SAO2: 96%
NUTRITIONAL STATUS
SKIN
> skin is brown smooth, warm, moist, with poor turgor and elasticity
HAIR
> Hair was shaved for the operation.
> Silky and smooth skin.
> No areas of hair loss noted.
NAILS
> Trimmed clean nails.
> Concave shaped; with a nail plate angle of about 160 degrees.
> Smooth in texture.
> Intact epidermal lining around the nails.
EYES AND VISION
> Anicteric sclera
REVIEW OF SYSTEM
Integumentary System
The patient has no history of bruises in both upper and lower extremities.
Head
The patient had no history of any form of head injuries.
Eyes
Patient had no history of any eye problems.
Ears and Hearing
Patient had no history of smelly discharges on both ears, and no complaints of
hearing impairment.
Breast and Axillae
The patient had no history of breast nodules, no enlargement, no tenderness, no
pain and unusual discharges.
Respiratory System
The patient has no history of asthma or other respiratory problems.
Cardiovascular System
The patient has a history of hypertension.
Genitourinary System
The patient had no history of any genital problems. Usually urinates at least 30cc
per hour.
Gastrointestinal System
Nervous System
The nervous system is broken down into two major parts: the central nervous
system, which includes the brain and spinal cord, and the peripheral nervous system,
which includes all nerves, which carry impulses to and from the brain and spinal cord.
These include our sense organs, the eyes, the ears, our sense of taste, smell and
touch, as well as our ability to feel pain.
Spinal Cord
10
The spinal cord is a long bundle of neural tissue continuous with the brain that
occupies the interior canal of the spinal column and functions as the primary
communication link between the brain and the rest of the body. The spinal cord
receives signals from the peripheral senses and relays them to the brain.
Brain
The brain is the largest and most complex part of the nervous system. It is
compose of more than 100 billion neurons and associated fibers. The brain tissues
have a gelatin like consistency. The semi-solid organ weighs about 1400g
(approximately 3 pounds) in the adult human.
11
The brain stem is the part of the brain that connects the cerebrum and
diencephalons with the spinal cord.
Medulla Oblongata
The medulla oblongata is located just above the spinal cord. This part of the
brain is responsible for several vital autonomic centers including
The medulla also controls other reflex actions including vomiting, sneezing, coughing
and swallowing.
Pons
Continuing up the brain stem, it reaches the Pons. The pons lay just above
the medulla and acts as a link between various parts of the brain. The pons connects
the two halves of the cerebellum with the brainstem, as well as the cerebrum with
the spinal cord. The pons, like the medulla oblongata, contains certain reflex actions,
such as some of the respiratory responses.
Midbrain
The midbrain extends from the pons to the diencephalon. The midbrain acts
as a relay center for certain head and eye reflexes in response to visual stimuli. The
midbrain is also a major relay center for auditory information.
Diencephalon
The diencephalons are located between the cerebrum and the mid brain. The
diencephalons houses important structures including the thalamus, the
hypothalamus and the pineal gland.
Thalamus
The thalamus is responsible for "sorting out" sensory impulses and directing
them to a particular area of the brain. Nearly all sensory impulses travel through the
thalamus.
Hypothalamus
The hypothalamus is the great controller of body regulation and plays an
important role in the connection between mind and body, where it serves as the
primary link between the nervous and endocrine systems. The hypothalamus
produces hormones that regulate the secretion of specific hormones from the
pituitary. The hypothalamus also maintains water balance, appetite, sexual behavior,
and some emotions, including fear, pleasure and pain.
12
Limbic System
The limbic system, often referred to as the "emotional brain", is found buried
within the cerebrum. Like the cerebellum, evolutionarily the structure is rather old.
Cerebellum (little brain)
The functions of the cerebellum include the coordination of voluntary muscles,
the maintenance of balance when standing, walking and sitting, and the maintenance
of muscle tone ensuring that the body can adapt to changes in position quickly.
Cerebrum
The largest and most prominent part of the brain, the cerebrum governs
higher mental processes including intellect, reason, memory and language skills. The
cerebrum can be divided into 3 major functions:
Meninges
The meninges are made up of three layers of connective tissue that surround
and protect both the brain and spinal cord. The layers include the Dura mater, the
arachnoid and the pia matter.
Pia mater is a vascular layer of connective tissue that is so closely connected
to the brain and spinal cord that is follows every sulcus and fissures.
Dura mater is a tough non-stretchable vascular membrane with 2 layers the
outer and inner layer.
Reflex Mechanism
Our conscious autonomic responses to internal and external stimuli known as
reflex responses provide many homeostatic functions. Although the spinal cord is
often thought of as the reflex center, it is not the only site for regulation .Many of the
complex reflexes controlling the heart rate, breathing, blood pressure, swallowing,
coughing, and vomiting are found in the brain stem.
Cerebrospinal Fluid
The cerebrospinal fluid is a clear liquid that circulates in and around the brain
and spinal cord. Its function is to cushion the brain and spinal cord, carry nutrients to
the cells and remove waste products from these tissues.
Neurons:
A neuronal cell body (soma) is like other cell in that it contains most of the
organelles seen in other cells.
13
There are several types of neurons - anaxonic neurons: small neurons where the
dendrites and axons are indistinguishable.
Bipolar neurons: small neurons with two distinct processes; a dendritic
process and an axon extending from the cell body.
Unipolar neurons: large neurons with the cell body lying to one side of the
continuous dendritic process and axon.
Multipolar neurons: large neurons with several dendrites and a single axon
extending from the cell body.
Bipolar neurons: Bipolar neurons are CNS neurons specific for transmitting
information from specialized sensory systems: sight, smell and hearing.
Grey and white matter: Grey matter consisting of unmyelinated neurons is the
processing area of the CNS. White matter located in the inner cortex and
surrounding grey matter in the spinal cord - provide pathways of communication
between grey matters.
Glial Cells
CNS Glial Cell Types: There are 4 types of glial cells:
1. astrocytes - Regulates the chemical microenvironment surrounding neurons.
2. Oligodendrocytes - Myelinate central nervous system axons.
3. Microglia - Migrating phagocytic cells resembling immune cells that remove
waste, debris, and pathogens.
4. Ependymal cells - Columnar cells that line the ventricles of the brain and the
spinal canal in the spinal cord.
Peripheral Nervous System
The PNS includes all neurons other than those in the brain and spinal cord. It
consists of pathways of nerve fibers between the CNS and all outlying structures in
the body. Included in the PNS are 12 pairs of cranial nerves and 31 pairs of spinal
nerves.
Nerves
Nerves are made up of specialized cells, which act as little wires, transmitting
information to and from the central nervous system and brain. Nerves form the
network of connections that receive signals (known as sensory input) from the
environment and within the body, and transmit the body's responses, or instructions
for action, to the muscles, organs, and glands. Nerve cells are located outside the
central nervous system or spinal cord.
Cranial Nerve
12 pairs of cranial nerves arise from the brain. Most of the cranial nerves are
composed of both motor and sensory neurons although a few cranial nerves carry
14
only sensory impulses. Except for the olfactory and optic nerves, whose nuclei lie just
below the cerebrum, all other cranial nerve nuclei lie within the brain stem
The Cranial Nerves
Nerves
Type
Function
I
Olfactory
sensor
y
olfaction (smell)
II
Optic
vision
sensor
(Contain 38% of all the axons connecting to
y
the brain.)
III
Oculomotor
motor
*
IV
Trochlear
motor
*
eyeball muscles
V
Trigeminal
mixed
VI
Abducens
motor
*
eyeball movement
VII
Facial
mixed
Sensory: taste
Motor: facial muscles and
salivary glands
VIII
Auditory
sensor
y
IX
Glossopharyng mixed
eal
Sensory: taste
Motor: swallowing
X
Vagus
mixed
XI
Accessory
motor
XII
Hypoglossal
motor
*
tongue muscles
15
These tumors originate from normal cells in the pineal gland. The pineal gland
is located in the center of the brain and is involved in the secretion of specific
hormones.
Tumor types occurring in the pineal region may or may not involve the pineal
gland. True pineal cell tumorspineocytoma, pineoblastoma, and mixed pineal
tumorsare covered on this page.
16
Tumors that may occur in this region but are not necessarily pineal tumors
include: germinoma, non-germinoma (eg, teratoma, endodermal sinus tumor,
embryonal cell tumor, choriocarcinoma, and mixed tumors), meningioma,
astrocytoma, ganglioglioma, and dermoid cysts. Information on these particular
tumors can be found elsewhere on this site.
Location
The pineal gland is located at the rear of the third ventricle, which is one of
the fluid-filled cavities of the brain. Pineal tumors come from the normal cells of the
pineal gland.
Description
There are three types of pineal tumors:
Pineocytoma: Slow-growing, grade II tumor.
Pineoblastoma: More aggressive, grade IV, malignant tumor. A grade III
intermediate form has also been described.
Mixed Pineal Tumor: Contains a combination of cell types.
Symptoms
17
Symptoms are most often caused by blockage of the cerebrospinal fluid flow
and problems with the eye movement pathways. Headache, nausea and vomiting,
and double vision are common.
Incidence
Pineal region tumors represent less than 1% of all primary brain tumors;
however, 3% to 8% of childhood brain tumors occur in this area. These tumors tend
to occur in young adults between 20 and 40 years old. About 10% to 20% of the
tumors, particularly pineoblastoma, have the potential to spread through the
cerebrospinal fluid. This usually occurs late in the disease. The tumors, however,
rarely spread elsewhere in the body.
Cause
Like many tumor types, the exact cause of pineal cell tumors is not known. However,
scientists have identified chromosomal abnormalities, which may play a role in the
development of these tumors.
Treatment
Standard treatment for these kinds of tumors is radiation therapy. Radiation of
the entire brain and spinal cord is recommended in patients with pineoblastoma.
Chemotherapy may also be considered, particularly if the tumor has spread or if it
regrows.
Surgery may be possible in some individuals to determine the tumor type and
remove part of the tumor. In some cases, placement of a shunt (similar to a drain) is
used to relieve pressure caused by buildup of cerebrospinal fluid.
Obstructive Hydrocephalus
18
19
the head. In addition, infants may suffer from symptoms such as vomiting,
drowsiness, irritability, constant downward gaze, poor appetite, or seizures. The same
symptoms may be present for toddlers and young children, along with headache,
nausea, fever, delayed progress in walking or talking, poor coordination, inability to
concentrate, or loss of sensory or motor functions.
In older children and adults, the bones of the skill are closed together and the
head cannot enlarge. Therefore, the symptoms of hydrocephalus reflect increased
pressure on the brain. These symptoms may include headache, loss of coordination
or balance, nausea, vomiting, bladder control problems, impaired vision, and changes
in concentration or memory.
Diagnosis
The diagnosis of hydrocephalus usually includes a physical and neurological
exam as well as imaging tests. The neurological exam checks eye movement and
vision, hearing, sensation, reflexes, balance and coordination, motor skills, thinking
and memory. Imaging tests such as MRI, CT scan, and ultrasound (for infants) can
help to determine the severity and cause of the hydrocephalus.
Treatment
The treatment of obstructive hydrocephalus depends on the cause of the
obstruction and the severity of the condition. If the hydrocephalus is not creating
symptoms, or if it is due to a temporary obstruction, intervention may not be
required. In most cases, though, it is necessary to have surgery. If the hydrocephalus
is due to a tumor or cyst that can be surgically removed, this is usually the best
option. However, sometimes the obstruction cannot be removed, so instead surgery
is required to divert the flow of CSF and avoid accumulation and pressure on the
brain. This approach does not cure the hydrocephalus, but it does address the
symptoms of the disease and allows for satisfactory long-term management.
There are two methods for diverting CSF. The first option is the surgical
insertion of a shunt. This is a small, flexible plastic tube that sends the excess CSF
into another area of the body where it can be safely absorbed, usually in cavities
near the abdomen or the heart. The shunt has a valve that controls the flow of CSF
and maintains normal pressure levels within the ventricle. All of the components of
the shunt system are enclosed in the body. The surgery to insert a shunt is a
relatively short and uncomplicated procedure. However, shunts have several
drawbacks. They can malfunction or become infected or clogged. Children tend to
outgrow the shunts and need later surgery to replace them.
The second method for diverting CSF is a relatively new, minimally invasive
procedure
called
ventriculoscopy
(sometimes
called
endoscopic
third
ventriculostomy, or ETV). In this treatment, the neurosurgeon uses an endoscope,
which is a tiny telescopic camera that can be inserted into the ventricle to view the
20
fluid and the obstruction. The surgeon can then create a hole in the membrane at the
bottom of the ventricle to allow the CSF to detour around the obstruction and flow
freely into the rest of the brain for re-absorption. Ventriculoscopy has many
advantages. When successful, it avoids the need for a shunt and it has a lower longterm complication rate than shunts. However, ventriculoscopy is not usually
recommended for children under two years of age, due to a higher rate of failure. In
addition, sometimes the first hole in the membrane closes up over time and the
procedure must be repeated. The procedure is also more complicated than a
traditional shunt surgery, so it is important that you have a neurosurgeon who is
trained in endoscopic techniques.
Surgery
Pineal region tumours
The pineal gland is just below the area where the two cerebral hemispheres
join. Tumours in this part of the brain are extremely rare. They can be made up of
different types of cells.
The most common tumours found in the pineal gland are germinomas; others
include teratomas, pineocytomas and pineoblastomas.
Symptoms of brain tumours
A brain tumour may cause symptoms because the space it takes up in the
skull puts pressure on the brain or because it is disturbing the function of the part of
the brain it's growing in.
Symptoms of brain tumour may occur due to following reasons:
Seizures
21
drowsiness. This can happen as the pressure in the brain increases. You may find
that you sleep more or that you drop off during the day when you wouldnt normally.
As well as the symptoms described here, raised intracranial pressure can also cause
changes to your sight, such as blurred vision, 'floating objects' and tunnel vision. It
may also make you confused or affect your balance. Seizures Seizures (fits) are
another common symptom caused by brain tumours. Some people can may
experience muscle spasms which could be twitching or jerking of an arm or leg or
sometimes the whole body. Occasionally they can cause moments of
unconsciousness.
It's important to remember that a seizure can be caused by medical
conditions other than a brain tumour. A seizure can be a frightening experience. if
you have one you should seek medical help so that the cause can be diagnosed and
treated.
Symptoms connected with the tumour's position
Some symptoms may be caused by tumours in particular parts of the brain.
Sometimes a headache can feel worse on the same side of the tumour. In general,
each area of the brain controls particular functions. A tumour in a particular part of
the brain may prevent that area of the brain from working normally.
Some of these symptoms are listed below, grouped under the different parts of the
brain. They are included only as a guide. Exact diagnosis can only be made by a
doctor and confirmed by tests.
The diagram showing the lobes and functions of the brain shows the different
functions of each area of the brain.
Frontal lobe tumours Changes in personality and intellect. Uncoordinated walking
or weakness of one side of the body, loss of smell, occasional speech difficulties.
Parietal lobe Difficulty speaking or understanding words. Problems with writing,
reading or doing simple calculations. Difficulty in coordinating certain movements,
and finding your way around. Numbness or weakness on one side of the body.
Occipital lobe Loss of vision on one side. The person may not notice this at first and
it may sometimes be discovered during routine eye tests.
Temporal lobe Fits, which may cause strange sensations: a feeling of fear or
intense familiarity (dj vu), strange smells or blackouts. Speech difficulties and
memory problems.
Cerebellum Lack of coordination which affects walking and speech (dysarthria),
unsteadiness, flickering involuntary movement of the eyes (nystagmus). Vomiting
and neck stiffness.
Brain stem Unsteadiness and an uncoordinated walk. Facial weakness, a one- sided
smile or drooping eyelid. Double vision. Vomiting or headache just after waking (this
is rare). Difficulty speaking and swallowing. Symptoms may appear gradually.
22
All the above symptoms may be caused by conditions other than a brain tumour. If
you have any of the symptoms described it is important that you go to see your GP.
Personality changes
Sometimes brain tumours may cause changes in personality or behaviour. These
symptoms usually occur when the tumour is in the brains cerebral hemispheres. This
situation can be very unsettling for the person and their family. Sometimes a referral
to a psychologist for assessment and support can help.
Driving
As brain tumours can cause changes in the way that your brain works, it may be
dangerous to drive. In the UK, there are laws which restrict some people with brain
tumours from driving for a time. The restrictions vary with the type of tumour you
have, and the type of driving license you hold.
However, you will not usually be allowed to drive for at least a year after the
condition has been diagnosed and in some circumstances you may not be able to
drive again. With some types of benign tumours you may be able to drive again once
you have recovered from your treatment.
It is your legal responsibility, not your doctor's, to tell the Drivers and Vehicle
Licensing Authority (DVLA) about your illness. The DVLA will advise of you of any
restrictions on your right to drive. You should also inform your car insurance
company.
How brain tumours are diagnosed
Usually, if you have slowly developing symptoms you'll see your GP, who will
examine you. If a brain tumour is suspected, they will refer you to a specialist doctor,
either:
An eye examination using an instrument that shines a light at the back of the
eye (ophthalmoscope). This test is done to see if the optic disc at the back of
23
Hearing tests.
Checking the strength of your arms and legs, and your reflexes.
A test of your ability to feel pinpricks on areas of skin, to tell the difference
between hot and cold, and possibly to recognize the feeling and shape of
familiar objects like coins.
Checking your balance and coordination, for example by asking you to walk a
few steps or perform repeated movements.
Biopsy
Skull x-ray
This test uses magnetic fields to build up a detailed picture of the inside of
your head. Before the scan you may be asked to complete and sign a checklist. This
is to make sure that its safe for you to have an MRI scan, because the scanner is a
powerful magnet. The checklist asks about any metal implants you may have, for
example a pacemaker, surgical clips, bone pins etc. You should also tell your doctor if
you have ever worked with metal or in the metal industry as very tiny fragments of
metal can sometimes lodge in the body. If you do have any metal in your body its
likely that you wont be able to have an MRI scan. In this situation another type of
scan can be used. Before having the scan, youll be asked to remove any metal
belongings including jewellery. You are usually given an injection of dye into a vein in
the arm, which doesnt usually cause discomfort. This is called a contrast medium
24
and can help the images from the scan to show up more clearly. During the test
youll be asked to lie very still on a couch inside a long cylinder (tube) that is open at
both ends. The whole test can take up to an hour. Its painless but can be slightly
uncomfortable, and some people feel a bit claustrophobic during the scan. Its also
noisy, but youll be given earplugs or headphones. You will be able to hear, and
speak to, the person operating the scanner. Brain CT (computerised tomography)
scan This is a series of x-rays, which builds up a three-dimensional picture of the
inside of your head. During the test you will be asked to lie with your head inside an
opening in the scanner. The scan is painless but takes longer than a normal x-ray
(from 5 to 10 minutes). It may be used to identify the exact area and size of the
tumour. Most people who have a CT scan are given an injection of a liquid into a vein,
to allow particular areas of the brain to be seen more clearly. The injection may make
you feel hot all over for a few minutes. Before having the injection, it is important to
tell your doctor and the person doing the scan if you are allergic to iodine or have
asthma or diabetes. You'll probably be able to go home as soon as the scan is over.
Biopsy
A patient having a CT scan
It's often necessary for the doctor to take a small part of the tumour (a biopsy) to find
out exactly what type of tumour you have (see Surgery for more information).
Skull x-ray
Very rarely, brain tumours may show up on an x-ray picture. The test is simple and
painless. You will have to lie on a couch in the hospitals x-ray department and you
will be asked to keep your head still for a few seconds.
PET (positron emission tomography) scan
A PET scan uses low-dose radioactive glucose (a type of sugar) to measure the
activity of cells in different parts of the body. A very small amount of the mildly
radioactive substance is injected into a vein, usually in your arm. Tumours normally
absorb more of the glucose and the radioactivity shows up on the scan.
25
After the injection you may be asked to lie in a dark room with your eyes
closed. You'll then be taken to the scanning room and asked to lie on a couch with the
scanning ring around you. The dose of radiation you receive is no more than a normal
x-ray.
A PET scan is not routinely used to diagnose a brain tumour but it may help to
tell whether a tumour is growing and whether it is cancerous (malignant) or benign.
PET scans arent available in all hospitals, and you may have to travel to a hospital
some distance away from your home to have one.
SPECT (single photon emission computerised tomography) scan
This test is similar to a PET scan. It can help to detect abnormalities in the
blood brain barrier as it looks at blood flow through the brain.
You are given an injection of a very mild radioactive substance, usually in your
arm. This susbstance travels in the blood to the brain. Then, in the scanning room,
pictures (scans) of the brain are taken.
Blood tests and chest x-rays
There isn't a specific blood test that can detect brain tumours, but you may
have blood tests to check your general health. A chest x-ray may also be done as
part of a general health check.
Treating brain tumours
26
a specialist nurse who gives information and support to people with brain
tumours. The MDT may also include other health care professionals, including
a:
dietitians
physiotherapists
occupational therapists
psychologists or counsellors.
Before you have any treatment, your doctor will explain its aims. They will
usually ask you to sign a form saying that you give your permission (consent) for the
hospital staff to give you the treatment. No medical treatment can be given without
your consent, and before you are asked to sign the form you should be given full
information about:
the type and extent of the treatment you are advised to have
If you do not understand what you've been told, let the staff know
straight away so that they can explain again. Some cancer treatments can be very
complex, so it's not unusual for people to need repeated explanations. It is often a
good idea to have a friend or relative with you when the treatment is explained, to
27
help you remember the discussion more fully. You may also find it useful to write
down a list of questions before you go to your appointment. Patients often feel that
the hospital staff are too busy to answer their questions, but it's important for you to
be aware of how the treatment is likely to affect you. The staff should be willing to
make time for you to ask questions. You can always ask for more time to decide
about the treatment if you feel that you cant make a decision when it is first
explained to you. You are also free to choose not to have the treatment. The staff
can explain what may happen if you do not have it. It is essential to tell a doctor or
the nurse in charge, so that they can record your decision in your medical notes. You
do not have to give a reason for not wanting to have treatment, but it can be helpful
to let the staff know your concerns so that they can give you the best advice.
Second opinion Your MDT use national treatment guidelines to decide on the most
suitable treatment for you. Even so, you may want another medical opinion. Either
your specialist, or your GP, will be willing to refer you to another specialist for a
second opinion, if you feel it will help. Getting a second opinion may cause a delay in
the start of your treatment, so you and your doctor need to be confident that it will
give you useful information. If you do go for a second opinion, it may be a good idea
to take a friend or relative with you, and have a list of questions ready; so that you
can make sure your concerns are covered during the discussion. The benefits and
disadvantages of treatment Often, people are concerned about the possible side
effects associated with treatment. Many of the treatments for brain tumours can
cause side effects.
However, improved ways of reducing or avoiding many of these problems
have made most of the treatments much easier to cope with.
Treatment can be given for different reasons and the potential benefits will
vary depending upon the individual situation. Surgery can be done with the aim of
curing some types of brain tumour. Occasionally additional treatments are also given
to reduce the risk of it coming back.
If the tumour is at a more advanced stage or in a part of the brain thats
difficult to reach without risk of damage, the treatment may only be able to control it.
This can lead to an improvement in symptoms and a better quality of life. However,
for some people in this situation the treatment will have little effect on the tumour
and they may get the side effects without any of the benefit.
If youve been offered treatment that aims to cure your brain tumour,
deciding whether to accept the treatment may not be difficult. However, if a cure is
not possible and the treatment is to control the tumour for a period of time, it may be
more difficult to decide whether to go ahead with treatment.
Making decisions about treatment in these circumstances is always difficult,
and you may need to discuss in detail with your doctor whether you wish to have
treatment. If you choose not to, you can still be given supportive (palliative) care,
with medicines to control any symptoms.
Treatment overview
With most primary brain tumours, surgery is often the first treatment if the
tumour can be removed without causing harm to the surrounding brain tissue.
However, certain tumours may not need to be operated on immediately, or at all.
28
Some low-grade gliomas, for example, may be carefully monitored if they are not
causing problems, and others may be treated with radiotherapy alone. Rare tumours
of the brain, such as germinomas or lymphomas, are sometimes treated without an
operation, using radiotherapy and chemotherapy.
Surgery can range from having a biopsy (see Surgery for more information) to
find out which type of tumour it is, to a major operation where the tumour is
completely removed.
Radiotherapy is often used after surgery. It may be given if a tumour has not
been completely removed, or if there is a chance that abnormal cells may be left
behind following surgery. Or, in the case of high-grade tumours, radiotherapy may be
recommended even if all of the tumour has been surgically removed.
When surgery is not possible, or not necessary, radiotherapy, with or without
chemotherapy, is used as the main treatment.
Symptom control treatment
In both primary and secondary brain tumours, treatment for particular symptoms
may be necessary. For example, anticonvulsant medicines to prevent seizures (fits)
and steroids to reduce any inflammation and swelling around the tumour.
Surgery for brain tumours
Very often a biopsy is used to find out exactly what type of brain tumour you have.
The biopsy may also be done as part of an operation to remove the tumour.
o
Biopsy
Craniotomy
Biopsy
29
biopsy). The surgeon uses the scan to help guide the needle to the right place.
Before the scan you may have markers stuck to parts of your head (called fiduciary
markers). These markers show up on the scan and help the surgeon guide the
needle to the affected area. Craniotomy Once the type of brain tumour is known, a
more extensive operation can be done to remove all or part of it. A craniotomy is an
operation that involves opening the skull. For this operation, you will be given a
general anaesthetic. However, you may be awake for at least part of the operation
(with the surgical area numbed) if doctors need to check your brain function during
surgery. This is called an awake craniotomy.
Some of your hair may need to be shaved off in the anaesthetic room before
the operation (doctors try to shave only as much as is necessary). The surgeon will
cut the scalp and the piece of skull over the tumour, remove the tumour itself, and
replace the piece of skull. The flap of scalp is then stitched back in place.
If its not possible, or advisable, to remove the whole tumour, only part of the
tumour is removed. This is called partial resection or debulking.
Sometimes the only way for the surgeon to remove the tumour is to go
through a healthy part of the brain, which may cause damage. The effects of this will
vary depending on the area of the brain involved. Your surgeon will talk this over with
you very carefully beforehand to make sure that youre fully aware of how the
surgery may affect you.
In some situations it will be too difficult or dangerous to remove even a small
part of the tumour, or the doctors may think that other treatments are more suitable.
Your surgeon or doctor will discuss the most appropriate type of operation with you
and, if you like, with a close relative or friend. Before any operation, do ask questions
so that you know exactly whats involved. No operation or procedure will be done
without your agreement.
After operation
The length of your stay in hospital will depend on the extent of the operation
and how well you are. For about the first 12 hours after the operation, youll be
closely observed, probably in the intensive care unit (ICU/ITU). You will probably have
frequent observations taken to begin with. These are known as neurological
observations, or neuro obs. They include checking how alert you are, testing your
reflexes, checking that your pupils react to light as well as checking your pulse, blood
pressure, the amount of oxygen in your blood and number of breaths each minute. At
first you may be cared for on a machine, which maintains your breathing (a
ventilator).
Its likely that your head will be bandaged and you may have a tube in the site
of the operation, which drains into a bottle. This is used to drain excess blood from
the head wound and is usually removed within a day or two. Your face and eyes may
be swollen and bruised after the operation. The swelling should go down within 48
hours and the bruising within a few days. You may also have a drip of salt water
(saline) to replace any fluids you may have lost and to keep you hydrated.
30
You may have a headache when you wake up after the operation and youll be
given painkillers to help relieve this.
Its unusual to get a lot of pain after surgery to the brain, but tell your nurse or
doctor if you are in pain or the pain starts to get worse.
These descriptions may sound dramatic but the effects of the operation
should settle fairly quickly and once staff are confident with your condition youll go
back to the ward to continue your recovery.
ShuntsBrain tumors can cause a wide variety of symptoms.
These are usually caused by a rise in pressure within the brain (raised
intracranial pressure). This happens when the tumour blocks the flow of the
cerebrospinal fluid (CSF) around the brain (this is called hydrocephalus). A shunt (also
called a ventricular catheter) may be inserted to drain excess fluid from the brain.
This will stop any further rise in intracranial pressure.
A shunt is a long, thin tube that is placed in the brain and then threaded under
the skin to another part of the body, usually into the lining of the abdominal cavity
(peritoneum). The tube allows excess fluid from the brain to drain into the abdominal
cavity where the body reabsorbs it. The shunt has valves in place so that fluid can
drain away from the brain but not back towards it.
The shunt is not visible outside of the body and you wont be able to feel it.
Steroids and anticonvulsant drugs
Before and after brain surgery, you'll be given steroid therapy and often
medicines known as anticonvulsant drugs to help to prevent seizures.
Steroid therapy
Steroids are drugs that are used to reduce the swelling that often surrounds
brain tumours. Although steroids don't treat the tumour itself, they help to improve
symptoms and make you feel better. They may be used before or after surgery, or
during or after radiotherapy.
Side effects of steroids
If you are taking steroids for some time, you may have temporary side effects.
These can include putting on weight, indigestion, raised blood pressure and a slightly
greater risk of getting infections, such as thrush (candida) in the mouth. Some people
also have mood changes, feel low or depressed; find it difficult to get to sleep or feel
'hyper' or over-active.
You may also develop a higher than normal level of sugar in the blood. If this
happens, your doctor will prescribe drugs, which you will need to take every day to
bring your blood sugar level back to normal. You may have to do a simple daily test
31
32
33
comfortable.
During your treatment, which will only take a few minutes, you'll be left alone
in the room but you can talk to the radiographer, who will watch you carefully from
the next
room. Radiotherapy is not painful but you do have to be still for a few minutes during
treatment.
Stereotactic radiotherapy and radiosurgery
These types of radiotherapy enable doctors to direct radiation more
accurately at brain tumours. The aim is to deliver higher doses of radiotherapy to the
tumour while doing as little harm as possible to surrounding brain tissue and to
minimise the side effects of treatment. It is sometimes given after standard external
radiotherapy or to treat small tumours that cannot be removed with surgery.
Stereotactic radiotherapy
This type of radiotherapy gives the treatment from a standard radiotherapy
machine which has been adapted. The machine gives concentrated beams of
radiation from several different angles which overlap at the brain tumour. This is
done either by moving the machine during treatment or by aiming individual beams
from a number of different directions.
The radiotherapy dose to the tumour is very high and the dose to surrounding
healthy tissues is very low. Several doses are given.
Before treatment, several scans of the brain are taken. These scans arethen analysed
by computers to ensure that the radiotherapy is precisely targeted to the brain
tumour. A special head frame will be made for you before you start treatment. This
frame helps to keep your head still while having the radiotherapy.
This treatment is only available in specialist hospitals and is not suitable for everyone
with a brain tumour. You could ask your clinical oncologist whether it would be
appropriate in your particular situation.
Stereotactic radiosurgery (gamma knife)
This is a type of stereotactic radiotherapy. It's sometimes called gamma knife
treatment, named after one of the machines that can be used to give this treatment.
Unlike stereotactic radiotherapy, sterotactic radiosurgery is given over one session,
as a single-dose treatment, taking about 4-5 hours.
It does not use a knife, but uses targeted beams of gamma radiotherapy given from
many different angles, which cross at the point of the tumour. You will have several
scans and x-rays to find the precise area for the treatment to be given. A special
head frame will be made for you before your start treatment. Thos frame helps to
keep your head still while having the radiosurgery.
34
Again, this treatment is only available in specialist hospitals and is not suitable for
everyone with a brain tumour. It may be helpful to discuss with your clinical
oncologist whether it's a suitable treatment for you.
Side effects of radiotherapy to the head
Side effects can be mild or more troublesome depending on the amount of
radiotherapy given and the length of your treatment. Radiotherapy can cause general
side effects such as tiredness, headaches, hair loss and feeling sick (nausea).
Tiredness
As radiotherapy often makes you feel tired, try to get as much rest as you can,
especially if you have to travel a long way for treatment each day.
JASCAP booklet on fatigue has helpful tips on ways of saving energy and dealing with
tiredness.
Headaches
Some people have headaches while they are having their radiotherapy. These
can be controlled with painkillers and sometimes steroids which will be prescribed by
your doctors.
Hair loss
You will lose hair within the area treated. Most hair loss is temporary but,
unfortunately, it may be permanent for some people. This will depend on the dose of
treatment you have had. Sometimes hair grows back with a slightly different colour
and texture and perhaps not as thickly as before. It usually starts to grow back within
23 months of finishing treatment.
Skin changes
Some people develop a skin reaction, similar to sunburn, while having
radiotherapy. This normally happens 34 weeks after the start of treatment. People
with pale skin may find that the skin in the treatment area becomes red and sore or
itchy. People with darker skin may find that their skin becomes darker and can have a
blue or black tinge. The amount of the reaction depends on the area being treated
and the individual persons skin. Some people have no skin problems at all.
Your radiographers will be looking for these reactions but you should also let
them know if you feel any soreness.
Staff at the radiotherapy department will be able to give you advice on skin
care. As the skin is sensitive it is best not to over-expose it to the sun or cold winds.
Try wearing a soft cotton or silk scarf or hat to cover the area when you go outside.
Somnolence (feeling drowsy)
35
Four to eight weeks after finishing after radiotherapy, you may find that you
generally slow down, have very little energy and feel much less active. You may also
feel drowsy and spend more time sleeping. It gradually gets better over a few weeks.
Feeling sick
Occasionally some people may feel sick but this can usually be treated
effectively by anti-sickness drugs (called anti-emetics), which your doctor can
prescribe. You may also find that food tastes different and you may have a metallic
taste in your mouth. If you dont feel like eating, you can replace meals with
nutritious, high-calorie drinks. These are available from most chemists and can also
be prescribed by your GP.
We have more information and helpful tips on how to cope with different
eating problems in our diet and cancer section.
After your treatment
Some people find the symptoms of the brain tumor temporarily get worse
after the treatment has finished. This can make them think their tumor is getting
worse. In fact it is either a reaction to the radiotherapy treatment or may be because
steroid treatment has been reduced or stopped.
If you find this happening to you it's important to discuss it with your doctor or
nurse, who'll be able to provide the right treatment and support.
Chemotherapy for brain tumors
Chemotherapy is the use of special anti-cancer (cytotoxic) drugs, which work
by disrupting the growth of cancer cells.
Chemotherapy is not used to treat all brain tumors. It may be used for people
with high-grade primary brain tumors where the tumor has come back. In this
situation chemotherapy is unlikely to be able to cure a brain tumors completely, but
it can sometimes shrink a tumor down or slow its growth and so can reduce
symptoms.
Chemotherapy drugs which may be used to treat primary brain tumours
include: lomustine (CCNU), procarbazine, vincristine and temozolomide (Temodal).
Some are given as tablets or capsules, and some are given by injection into a vein
(intravenously). Sometimes lomustine, procarbazine and vincristine are used
together and this combination of chemotherapy drugs is known as PCV.
Another way of giving chemotherapy is by an implant, which can be placed
into the area of the brain tumors during surgery. These implants (called Gliadel
implants) are small gel wafers or discs, which contain the chemotherapy drug
carmustine. As the gel wafer dissolves, the drug is slowly released.
The type of chemotherapy you have will depend on the type and stage of the
36
brain tumors. Chemotherapy to treat brain tumors can usually be given to you as an
outpatient. Chemotherapy may sometimes be used after surgery, or with, and after
radiotherapy in people who have just been diagnosed with a brain tumor.
The National Institute for Health and Clinical Excellence (NICE) is an
independent body that was set up by the government. NICE assesses medicines and
treatments and gives guidance to doctors on how they should be used in the NHS in
England and Wales. The equivalent body in Scotland is the Scottish Medicines
Consortium (SMC).
C
urrent NICE guidance on the use of carmustine (Gliadel) implants and
temozolomide recommends carmustine implant as a possible treatment for people
with newly diagnosed high-grade glioma only if 90% or more of their tumors has been
removed. People should have carmustine implants only at specialist treatment
centres under the care of a team of experts. Temozolomide is recommended as a
possible treatment for people with a type of high-grade glioma called a glioblastoma
who are newly diagnosed and fit and well enough to have it.
Both of these drugs have been assessed by the SMC and have been approved for use
in Scotland.
Side effects
Chemotherapy can cause side effects, which can be unpleasant, and for some
people chemotherapy may have little effect on the tumors. So they will have the side
effects without any noticeable benefits. The fitter a person is, the more likely they are
to benefit from the chemotherapy and the less likely to have side effects.
Making decisions about treatment under these circumstances is always difficult. It will
be helpful to discuss with your doctors the possible benefits and side effects of
chemotherapy in your situation. You can also speak to our cancer support specialists.
Many people have few side effects and those that occur can often be well controlled
with medicine. The main side effects are described here, together with some of the
ways they can be reduced.
Lowered resistance to infection
While the drugs are acting on the cancer cells in your body they also
temporarily reduce the number of normal white blood cells. When these cells are
reduced you're more likely to get an infection and you may tire more easily. During
chemotherapy your blood will be tested regularly and, if necessary, you may be given
antibiotics to treat any infections.
If your temperature goes above 38C (100.5F), or you suddenly feel unwell even
with a normal temperature, contact your doctor at the hospital straight away.
37
Anemia
If the level of red blood cells in your blood is low you will become very tired
and lethargic. You may also become breathless. These are symptoms of anemia. If
you become very anemic, you may be given a blood transfusion.
Bruising and bleeding
Platelets are a type of cell that helps to clot the blood. If the number of
platelets in your blood is low you will bruise very easily and may bleed heavily from
even minor cuts or grazes. If you develop any unexplained bruising or bleeding, such
as nosebleeds, blood spots or rashes on the skin, or bleeding gums, contact your
doctor or the hospital immediately.
Feeling sick
Some chemotherapy drugs may make you feel sick (nauseated) and can also
make you be sick (vomit). There are now very effective anti-sickness drugs (antiemetics) to prevent or greatly reduce nausea and vomiting. Your doctor can prescribe
these for you.
If you dont feel like eating during treatment, you could try replacing some meals
with nutritious drinks or a soft diet - our section on eating well, has some useful tips
on coping with eating problems.
Hair loss
The chemotherapy drugs commonly used to treat brain tumors don't usually
cause hair loss but some may cause hair-thinning. If your hair does fall out while you
are having chemotherapy, it will grow back over a period of 36 months.
Tiredness
It is important to remember that chemotherapy affects people in different
ways. Some people find that they are able to lead a fairly normal life during their
treatment, but many others find they become very tired and have to take things
much more slowly. Just do as much as you feel like and try not to get too tired.
Although the side effects may be hard to bear at the time, they will gradually
disappear once your treatment is over.
38
39
V. Pathophysiology
Non-Modifiable Factors:
Modifiable Factors:
Etiology:
Unknown
Chemical exposure
Exposure to radiation
Formation of mass in
pineal region of the brain
Compression in the
adjacent structures
(+) H/A
(+) nausea
(+) vomiting
(+) Fatigue
(+) Visual Impairment
(+) Memory Problems
(+) Seizure
Caused by aqueducal
compression
40
OBSTRUCTIVE HYDROCEPHALUS
Aqueductal Stenosis
41
Developmental delay
Since, fontanels are closed in
adults no enlargement of the
brain manifestation
Neuromuscular
Skills
(+) Poor
motor skills
Impaired
neuromuscular
coordination
(+) Unable
to stand or
sit
Loss of
control
and
awareness
Risk for
injury
related to
neuromuscul
ar
impairment
Manifested by Sunken
fontanels, (+) dry skin and
(+) poor skin turgor
Fluid volume deficit
related to inadequate
intake
Ineffective airway
clearance related to
inability to
expectorate mucus
42
Diagnostic/
Laboratory
Procedures
1. Complete Blood
Count
Date ordered
Date Results in
Indications or
Purposes
Results
Analysis and
Interpretation of
results
CBC is a screening
test, used to
diagnose and
manage numerous
diseases. The
results can reflect
problems with
fluid or loss of
blood.
43
a. Hemoglobin
Date ordered/
Hemoglobin
determines the
Date of Results: RBC that carries
oxygen and
July 27, 2015
carbon dioxide
throughout the
body
Date ordered/
b. Hematocrit
Hematocrit
Date of Results:
determines the
concentration of
July 27, 2015
RBC within the
Hgb: 13.1
N: 14.1-18.1 g/L
Hct: 37.5
N: 43.5-53.7
blood volume
44
RBC: 4.71
c. RBC
Date ordered/
N:4.7-5.1
RBCs
contain
hemoglobin,
which
carries
oxygen.
How
much
oxygen
your body tissues
get depends on
how many RBCs
you have and
how well they
work.
45
Date ordered/
Date of Results:
d. WBC
WBC: 14.30
N: 4.5-10.2 x 109/L
46
DIFFERENTIAL COUNT
Date ordered/
Lymphocytes: 45 %
Date of Results:
A.Lymphocytes
Lymphocytes are
responsible
for
immune
responses. There
are
two
main
types
of
lymphocytes:
B
cells and T cells.
The B cells make
antibodies
that
attack
bacteria
and toxins while
the T cells attack
body
cells
themselves when
they have been
taken over by
Date ordered/ viruses or have
become
Date of Results: cancerous.
N: 100-500 %
0.00
47
d. Monocytes
Lymphocytes
secrete products
(lymphokines)
that
modulate
the
functional
activities of many
other types of
cells
and
are
often present at
sites of chronic
inflammation.
Eosinophils are a
specific type of
white blood cell
that
protects
Date ordered/
your
body
against
certain
Date of Results:
kinds of germs,
July 27, 2015
mainly
bacteria
and
parasites.
They're also what
causes you to
have
allergic
reactions.
N: 0.00-0.7.0
3.5
N: 0.0-14.0
48
e. Basophils
0.1
N: 0.0-1.5
Basophils
are
granulocytic
white blood cells
that are active in
the inflammatory
response.
They
are mostly found
Date ordered/
in the skin and
Date of Results: mucosa tissues,
which are the
tissues lining the
July 27, 2015
openings into the
49
body.
They
represent about
1% of all white
blood cells in the
body.
Platelet Count
Platelet Count:
311
Platelet Count:
14.7 sec.
150- 400 x 109/L
The result is within the
normal range indicates
that there is enough
platelet produces for
coagulation.
Date ordered/
Date of Results:
July 27, 2015
14.7 sec.
Prothrombin Time
A platelet count
is
a
test
to
measure
how
many
platelets
you have in your
blood.
Platelets
are parts of the
blood that help
the blood clot.
They are smaller
than red or white
blood cells.
11.3-15.3 sec.
50
Date ordered/
Activity
APTT
Prothrombin time
(PT) is a blood
Date of Results: test
that
measures
how
July 27, 2015
long
it
takes
blood to clot. A
prothrombin time
test can be used
to
check
for
bleeding
problems. PT is
also
used
to
check
whether
medicine
to
prevent
blood
clots is working.
82%
70-100%
Date ordered/
Date of Results:
July 24, 2015
Diagnostics:
A
factor
VIII
activity blood test
lets
doctors
51
MRI
evaluate
the
functioning of a
protein that helps
blood to clot.
The PTT is used
primarily
to
investigate
unexplained
bleeding
or
clotting. It may be
ordered along with
a prothrombin time
(PT)
test
to
evaluate
hemostasis,
the
process that the
body uses to form
blood clots to help
stop
bleeding.
These tests are
usually the starting
points
for
investigating
excessive bleeding
clotting
Date ordered/ or
disorders.
Date of Results:
52
Urinalysis
(NMRI),
or
magnetic
resonance
tomography (MRT)
is
a
medical
imaging technique
used in radiology
to investigate the
anatomy
and
physiology of the
Date ordered/ body in both health
and disease. MRI
use
Date of Results: scanners
magnetic
fields
July 28, 2015 and radio waves to Color:
form images of the
body.
The Yellow
technique is widely
used in hospitals
for
medical
diagnosis, staging Transparency:
of
disease
and
follow-up without Slightly turbid
exposure
to
ionizing radiation.
.
The clients CT scan
result indicates
abnormalities of
hydrocephalus.
Yellow
Amber
SP Gravity:
1.020
clear 4.8-7.8
The result has a normal
color
Sugar: negative
1.015-1.025
A CT scan has
many uses, but is
particularly wellsuited to quickly
Protein: +2
53
examine people
who may have
internal injuries
from car accidents
or other types of
trauma. A CT scan
can be used to
visualize nearly all
parts of the body
and is used to
diagnose disease
or injury as well as
to plan medical,
surgical or
radiation
treatment.
Negative
RBC: 2.5
Epithelial cells:
There is no presence of
sugar
Negative
0.1/HPF
few
There is no presence of
protein
0.2/HPG
Mucus threads:
Indicate presence
of
few
Infection
Few
Urinalysis yields
a large amount of
information about
possible
disorders of the
kidney and lower
urinary tract, and
systemic
disorders
that
alter
urine
composition
Indicates no presence of
infection
54
55
Nursing Responsibilities:
BEFORE
1. Explain to the patient the procedure and its purposes.
2. If the patient has eaten a meal with high sodium content in the past 24 hours, this
should be noted.
3. Be sure not to draw blood, which has infused IVF.
4. Note if patients on a diet that restricts sodium and other nutrients.
5. Note other conditions such as diabetes.
6. Carefully watch for signs of electrolyte imbalance.
7. Perform a complete cephalocaudal assessment especially cardiac assessment and
vital signs.
8. Make sure to have the right patient, specimen and method.
DURING
1. Clean injection site with alcohol.
2. Lower the patients arm to dilate the veins.
3. Apply tourniquet and ask the patient to open and close fist.
4. Remove the tourniquet when drawing the final tube of blood.
AFTER
1. Note for any signs of discomfort or bruising at the puncture site.
2. Provide pressure at the puncture site to stop bleeding and reduce bruising.
3. Apply warm compress to puncture site to relieve discomfort.
4. Send the specimen at the laboratory.
56
B. Blood Chemistry
Diagnostic/
Laboratory
Procedures
Date ordered
Date results in
Indications or
Purposes
Date ordered:
A serum creatinine
test which
measures the level
of creatinine in
your blood can
indicate whether
your kidneys are
working properly.
Results
Normal Value
(Units used
in the
hospital)
Analysis and
Interpretation of
results
2. CLINICAL
CHEMISTRY TEST
Creatinine
Date of Results:
July 27, 2015
Sodium
Date ordered:
It regulates body
water along with
67.70 umol/L
Na: 138.10
N: 45-104
umol/L
N: 1135-145
57
Date of Results:
potassium. It is
responsible
for
nerve conduction
and contraction of
muscle.
mmol/L
indicates
presence
hypernatremia
hyponatremia
no
of
or
Potassium
Date ordered:
July 27, 2015
Date of Results:
It is a mineral,
which with Sodium
and
Calcium
maintains normal
heart rhythm and
regulates
water
balance.
K: 4.10
N: 3.5-5.3
mmol/L
58
NURSING RESPONSIBILITIES
BEFORE
1. Confirm the patients identity using two patient identifiers according to facility policy.
2. Explain the procedure and the indication.
3. Inform the patient that the test requires blood sample, and explain that he may
experience slight discomfort from the tourniquet and the needle puncture.
4. Instruct the patient that he doesnt need to restrict food and fluids. For triglycerides
she should not eat 12 hours before procedure.
5. Notify the laboratory and practitioner about any medications the patient is taking
that may affect test results; they may need to be restricted.
DURING
1. Perform venipuncture and collect the sample in a 3- or 4-mL clot activator tube.
2. Handle sample gently to prevent hemolysis.
AFTER
1. A report of the results will be sent to the requesting Health Care Provider, who will
discuss the results with the patient.
2. Depending on the results of this procedure, additional testing may be performed to
evaluate or monitor progression of the disease process and determine the need for a
change in therapy.
3. Evaluate test results in relation to the patient's symptoms and other tests performed.
59
DURING
1. Provide privacy.
2. Decrease discomfort, and anxiety, allows adequate time.
3. Tell the patient to assume a normal voiding position.
4. Introduce stimuli for voiding.
5. Pour warm water over the perineum.
6. Collect a clean catch urine sample during midstream urination.
AFTER
1. Ensure that the specimen label and laboratory requisition form are filled out correctly.
2. Securely attach the label to the container.
3. Send the specimen to the laboratory at once.
4. Document what you have done.
60
61
NURSING
DIAGNOSIS
SPECIFIC
EXPLANATION
PLANING
1.
S:
O:Patient
manifested the
following:
>Febrile, T=38C
in both axilla;
warm to touch
with flushing
Hyperthermia
r/t increase
Intracranial
pressure
ENTRY OF PATHOGEN
IN THE SYSTEMIC
CIRCULATION
REGULATION OF
TOXIN IN THE BODY
Patient may
manifest:
Nausea
NURSING
INTERVENTION
Short Term:
After 2-3 hours of
nursing
intervention the
patient will be able
to decrease body
temperature from
40 C to 37C.
2.
3.
4.
RELEASE OF PYROGEN
Long Term:
Vomiting
Fatigue
STIMULATION OF THE
HYPOTHALAMUS
Pallor
Initial Vital
signs:
INCREASE OR
ALTERRATION OF
THERMOREGULATION
After 2 days of
nursing
intervention the
patient will be to
maintain normal
body temperature
5.
Do/perform
tepid sponge
bath
Assess body
temperature
from time to
time
Do not apply
alcohol for
TSB
RATIONALE
1.
2.
To know
what is the
response of
client to TSB
3.
Alcohol
increases
peripheral
vascular
constriction
&CNS
depression
Advise the so
to increase
oral fluid
intake of the
patient
Remove
excess
clothing and
covers
4.
Additional
fluids help
prevent
elevated
temperature
associated
with
dehydration
5.
These
decrease
warmth and
increase
evaporative
cooling
BP: 145/79
PR: 95
RR: 39
INCREASE BODY
TEMPERATURE
T: 40
To help
decrease bo
dy
temperature
EVALUATION
Short Term:
The patient
shall
Demonstrated
temperature
within normal
range, from
40C to 37.5C
Long Term:
The patient
shall have
demonstrated
behaviors to
monitor and
promote
normothemia
HYPERTHEMIA
62
SP02: 100%
63
64
Independent:
S:
O: Patient
manifested
the
following:
Ineffective
cerebral
perfusion
related to
interruption
of blood flow
Intracranial
pressure
Pressure exerted
in the cranium
by its content
>Unconscious
Patient may
manifest:
nausea
vomiting
fatigue
Initial Vital
signs taken:
Associated with
vasospasm or
obstruction in
the arteries
supplying the
brain with blood
BP: 145/79
PR: 95
Increase
vascular
Short Term:
After 2-3 hours
of nursing
intervention the
SO will
verbalized
understanding
of condition,
therapy
regimen and
when to contact
health provider
Long Term:
After 2 days of
nursing
intervention the
patient will
demonstrate
behaviors and
life style
changes to
improve
circulation such
as relaxation
techniques.
1. Assess
patient
condition
2. Position
head slightly
elevated and
in neutral
position
3. Take
patients
temperature
at least 4
hours
4. Keep
patients in
neutral
alignment
5. Provide
quite, restful
environment
.
6. Note history
of
brief/intermit
tent periods
or black out.
1. To be able to
identify
present
physiologic
disturbances
2. Reduces
arterial
pressure by
promoting
venous
drainage and
may improve
cerebral
perfusion.
3. Hyperthermia
causes
increased ICP
hypothermia
causes
decrease
cerebral
perfusion
pressure
4. To keep the
carotid flow
unobstructed
thereby
promoting
perfusion
5. Continual
stimulation
can increase
Short
Term:
The So shall
have
verbalized
understandi
ng of
condition,
therapy
regimen and
when to
contact
health care
provider
Long Term:
The patient
shall have
Demonstrat
ed
behaviors
and life
style
changes to
improve
circulation
65
RR: 39
resistance can
result due to
increase ICP
T: 40
SP02: 100%
Leading to
decrease and or
absence of blood
flow to the brain
cells
Because of this
there will be
decrease or
absence of
oxygen supply to
the brain cells
7. Monitor
patients
behavior and
mental
status for
onset of
restlessness,
agitation
confusion
Dependent:
8. Administer
supplementa
l oxygen.
ICP.
6. Because this
suggest
transient
ischemic
attacks
7. Changes in
behavior and
mental status
are sign of
altered
cerebral
perfusion
such as
relaxation
techniques.
8. Reduces
hypoxemia,
which can
cause cerebral
vasodilatation
and increase
pressure/
edema
formation.
So there is
ineffective
cerebral
perfusion
66
ASSESSMENT
NURSING
DIAGNOSIS
Scientific
EXPLANATION
PLANING
NURSING
INTERVENTION
RATIONALE
EVALUATIO
N
67
S:
O: Patient
manifested
the
following:
> Unconscious
Patient may
manifest:
Altered neuronal
cells
Increased
frequency and
amplitude
Short Term:
After 2-3 hours
of nursing
intervention the
patients
seizures will be
lessen
dizziness
fall
Neuronal firing
spreads
Long Term:
nausea
Initial Vital
signs taken:
Seizures
BP: 145/79
PR: 95
RR: 39
Unpredictable
movement or
behavior
After 2 days of
nursing
intervention the
patients seizures
will be remove
1. Assess
patient
condition
2. Keep padded
side rails up
with bed in
the lowest
position
3. Provide
information
regarding
the condition
that may
result in risk
for injury.
4. Assess
muscle
strength
gross and
fine motor
coordination
5. Keep the
patients
room free
from clutter
1. To be able
to identify
present
physiologic
disturbance
s
2. Minimizes
injury while
patient is in
bed
Short
Term:
The
patients
seizures
shall be
lessen
3. To promote
awareness
4. to
determine
the severity
of body
weakness
and to be
able to
perform
appropriate
interventio
n
5. to promote
individual
safety
Long Term:
The
patients
seizures
shall be
removed
T: 40
SP02: 100%
68
MEDICAL
MANAGEMENT/
TREATMENT
DATE ORDERED,
DATE PERFORMED,
DATE CHANGE
GENERAL
INDICATION OR
DESCRIPTION
PURPOSES
CLIENTS
RESPONSE TO
TREATMENT
An aqueous solution
PNSS 1L x KVO
Date ordered:
July 28, 2015
Date of Results:
July 28 & 29, 2015
This is indicated
for fluid
hydrated as
replacement for
evidenced by
fluid, used in
hypotension. It is
continuous infusion,
improvement in his
sterile form.
medications.
were no negative
maintain normal
effects noted.
potassium level.
69
NURSING RESPONSIBILITIES
Prior to procedure:
Apply tourniquet 4-6 inches above the sites apply identify suitable vein
Raise bed for comfortable working height and position for patient and
adjust lighting
Explain to the client what you are doing to do, why it is necessary, and
how she can cooperate
Apply a new tourniquet for each patient and palpate for a pulse distal
to the tourniquet
With hand not holding the venous access devise, steady patients arm
and use finger to pull skin taut
Hold needle hub, and slide catheter over the needle and vein
70
Remove while pressing lightly on the skin over the catheter tip
Cover and tape the small loop of IV tubing onto the dressing
71
b. Diet
TYPE OF DIET
DATE ORDERED,
GENERAL
DATE
DESCRIPTION
SPECIFIC FOOD
CLIENT'S
TAKEN
RESPONSE AND
TAKEN/GIVEN,
REACTION TO
DATE CHANGED
THE DIET
Date ordered:
NPO (Nothing per
INDICATION
Orem)
NPO
stands
for
which
through mouth.
means
nothing by mouth.
Doctors use this
Date of Results:
July 28 & 29, 2015
Patient cannot
on
orders
None
when
any
type
of
food or liquid by
mouth.
For
instance, when a
patient is getting
ready
for
72
During:
After:
73
TYPE OF DIET
DATE
GENERAL
ORDERED,
DESCRIPTION
INDICATION
SPECIFIC FOOD
CLIENT'S
TAKEN
RESPONSE
DATE
AND REACTION
TAKEN/GIVEN,
TO THE DIET
DATE
CHANGED
NGT
Date ordered:
July 28, 2015
These are
It
special
preparations for
patients who are
unable to digest
solid foods.
It is indicated to
TEN and
prevent further
medications
to get full
increase in the
patients blood
TEN.
pressure and to
lower down
Date of Results:
cholesterol
levels.
74
75
c. Foley Catheter
76
MEDICAL
MANAGEMENT/
DATE ORDERED,
DATE
PERFORMED,
TREATMENT
DATE CHANGE
Foley Catheter
Date ordered:
INDICATION OR
GENERAL DESCRIPTION
Date of Results:
July 28 & 29, 2015
RESPONSE TO
TREATMENT
To drain urine
The treatment
when the
resulted to a non-
bladder's muscles
palpable bladder
with a proper
working properly.
excretion of urine
Also, certain
channels, or lumens,
medications can
emptying.
A Foley catheter is a
PURPOSES
CLIENTS
bladder's normal
who are
incapacitated
because of critical
To measure urine
output in adults
To drain urine in
illness or surgery.
To collect urine
during diagnostic
studies of the
urinary tract.
77
d. Medications
NAME OF
DRUGS,
GENERIC NAME,
BRAND NAME
DATE
ORDERED,
DATE
TAKEN/GIVEN,
DATE
CHANGED
ROUTE OR
ADMINISTRATIO
N DOSAGE AND
FREQUENCY OF
ADMINISTRATIO
N
Dosage:
600mg
Generic name:
Paracetamol
Brand name:
Calpol
Route:
IV
GENERAL
ACTION,
MECHANISM OF
ACTION
General Action:
Analgesics
Muscle Relaxants
Frequency:
q 6hrs
INDICATION
OR
PURPOSES
Relief of mildto-moderate
pain;
treatment
of
fever.
CLIENTS
RESPONSE TO
THE
MEDICATION
Clients response
to medication is
effective as
evidence by
lowering down
the patients
temperature
Mechanism of
Action:
-Decreases fever
by inhibiting the
effects of
pyrogens on the
hypothalamus
heat regulating
centers & by a
hypothalamic
-Action leading to
sweating &
vasodilatation.
78
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
Dosage:
30mg
GENERIC NAME:
Ketorolac
BRAND NAME:
Toradol
GENERIC NAME:
Tramadol
BRAND NAME:
Ultram
GENERAL
ACTION,
MECHANISM OF
ACTION
INDICATION
OR PURPOSES
General Action:
Short
term
management of
Nonsteroidal antipain (not to
ROUTE
OR
GENERAL
exceedACTION,
5 days
inflammatory
total
for
ADMINISTRATION
agents, nonopioid MECHANISM OFall
routes
DOSAGE
AND
ACTION
analagesics
combined)
FREQUENCY OF
ADMINISTRATION
Mechanism of
Action:
Dosage:
General Action:
50mg
- Inhibits
Analgesics
prostaglandin
Route:
(centrally acting)
IV synthesis,
producing
Frequency:
peripherally
q 8hrs
PRN analgesia
Mechanism of
mediated
Action:
- Also has
antipyretic and -Decreased pain.
anti-inflammatory
-Binds to mu-opioid
properties.
receptors.
- Therapeutic
effect:Decreased -Inhibits reuptake of
serotonin and
pain
norepinephrine in
the CNS.
CLIENTS
RESPONSE TO
THE
MEDICATION
Client responded
well with the
medication given
INDICATION
as evidenced by
OR PURPOSES
observations of
relieved pain.
Moderate
moderately
severe pain
to
CLIENTS
RESPONSE TO
THE
MEDICATION
Client shows
decrease
restlessness due
to pain.
79
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
Dosage:
500mg
GENERIC NAME:
Tranexamic Acid
Route:
IV
Frequency:
q 8hrs
GENERAL ACTION,
MECHANISM OF
ACTION
General Action:
Hemostatic agents
Fibrinolysis
inhibitors
INDICATION OR
PURPOSES
Treatment
of
severe localized
bleeding
secondary
to
hyperfibrinolysis
CLIENTS
RESPONSE TO
THE
MEDICATION
Client responded
well with the
medication as
evidenced by
bleeding is
controlled.
BRAND NAME:
Lysteda
Mechanism of
Action:
Tranexamic acid
competitively
inhibits activation of
plasminogen
thereby reducing
conversion of
plasminogen to
plasmin
(fibrinolysin), an
enzyme that
degrades fibrin
clots, fibrinogen,
and other plasma
proteins, including
80
the procoagulant
factors V and VIII.
81
82
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
Dosage:
1gm
GENERIC NAME:
Oxacillin
BRAND NAME:
Bactocill
Route:
IV
Frequency:
q 6hrs
GENERAL
ACTION,
MECHANISM OF
ACTION
General Action:
Penicillinase
Mechanism of
Action: Resistant
penicillin that
inhibits cell-wall
synthesis during
microorganism
multiplication;
bacteria resists
penicillins by
producing
penicilllinase
enzymes that
convert penicillins
to inactivate
penecillic acids.
Oxacillin resists
these enzymes.
INDICATION
OR PURPOSES
CLIENTS
RESPONSE TO
THE
MEDICATION
Systemic
infections
caused
by
penicillinaseproducing
staphylococci
Client responded
well with the
medication as
evidenced by
infection is
controlled.
83
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
ROUTE OR
DATE ORDERED,
NAME OF DRUGS,
ADMINISTRATION
DATE
GENERIC NAME,
DOSAGE AND
TAKEN/GIVEN,
BRAND NAME
FREQUENCY
OF
DATE CHANGED Dosage:
ADMINISTRATION
1gm
GENERIC NAME:
DO: July 28, 2015
Route:
Dosage:
IV
Ceftriaxone
DG: July 28 & 29,
100mg
GENERIC NAME:
DO: 2015
July 28, 2015
Frequency:
Route:
q 12hrs
Phenytoin
DG: July 28 & 29, IV
BRAND NAME:
2015
Frequency:
Rocephin
q 8hrs
BRAND NAME:
Dilantin
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
GENERAL ACTION,
MECHANISM OF
ACTION
GENERAL
ACTION,
MECHANISM OF
General
Action:
ACTION
Antimicrobial and
General Action:
Antiparasitic
Antiepileptic agent,
Hydantoin
Mechanism of
Action:
Mechanism of Action:
Inhibits bacterial
cell
synthesis,
Haswall
antiepileptic
rendering
cell wall
activity without
osmotically
causing general CNS
depression;
stabilizes
unstable,
leading
to
neuronal
membranes
cell death
and prevents
hyperexcitability
caused by excessive
stimulation; limits the
spread of seizure
activity from an
active focus; also
effective in treating
cardiac arrhythmias,
especially those
induced by digitalis;
antiarrhythmic
properties are very
similar to those of
lidocaine; both are
class IB
antiarrhythmic
INDICATION OR
PURPOSES
INDICATION
OR PURPOSES
Treatment
of
LRIT
(e.g.
bronchitis,
pneumonia, of
-Control
bronchopneumo
grand
mal
nia, emphysema,
(tonic-clonic)
lungabscess),
and
skin and soft
psychomotor
tissue infections.
seizures
Pre-operative
prophylaxis
-Prevention
and
toreduce chance
of
posttreatment
of
operative
seizures
surgical
occurring
infections.
during
or
following
neurosurgery
CLIENTS
RESPONSE TO
THE
MEDICATION
CLIENTS
RESPONSE TO
THE
Client
responded
MEDICATION
well with the
medication as
Client
responded
evidenced
by
well
with the
infection
is
medication
controlled. as
evidenced by
treatment of
some episodes of
seizures
-Control
of
status
epilepticus
of
the grand mal
type (parenteral
administration)
84
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
Dosage:
100c
GENERIC NAME:
Mannitol
Route:
IV
Frequency:
q 6hrs
GENERAL ACTION,
MECHANISM OF
ACTION
General Action:
Electrolytic and
water balance
agent; osmotic
diuretic
BRAND NAME:
Osmitrol
Mechanism of
Action:
In large doses,
increases rate of
electrolyte excretion
by the kidney,
particularly sodium,
chloride, and
potassium.
INDICATION OR
PURPOSES
Induces diuresis
by
raising
osmotic pressure
of
glomerular
filtrate, thereby
inhibiting tubular
reabsorption of
water
and
solutes. Reduces
elevated
intraocular and
cerebrospinal
pressures
by
increasing
plasma
osmolality, thus
inducing
diffusion of water
from these fluids
back into plasma
and
CLIENTS
RESPONSE TO
THE MEDICATION
Client responded
well with the
medication as
increased urine
output.
extravascular
space.
85
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
Dosage:
NAME OF DRUGS, DATE ORDERED, 500mg
ROUTE OR
GENERIC
NAME:
DO:
July
28,
2015
GENERIC NAME,
DATE
ADMINISTRATION
BRAND NAME
TAKEN/GIVEN, Route:
DOSAGE AND
Levetiracitam
DG: July 28 & 29, Oral capsule
DATE CHANGED
FREQUENCY OF
2015
ADMINISTRATION
Frequency:
BID
BRAND NAME:
GENERIC NAME:
Keppra
Omeprazole
BRAND NAME:
Losec
Dosage:
40mg
DO: July 28, 2015
DG: July 28 & 29,
2015
Route:
IV
Frequency:
OD
GENERAL
ACTION,
MECHANISM OF
ACTION
General Action:
GENERAL
anti-epileptic
ACTION,
MECHANISM OF
anticonvulsant
ACTION
Mechanism of
General Action:
Action:
Gastrointestinal
Appears to inhibit
Agent; Proton
burst firing without
pump inhibitor
affecting normal
neuronal
excitability and
Mechanism
of
may
selectively
Action:
prevent
hypersynchronizati
An of
antisecretory
on
epileptiform
compound
burst firing that
and is a
gastric
acid
propagation pump
of
inhibitor.activity,
seizures
Suppresses gastric
acid secretion by
inhibiting the H+,
K+- ATPase
enzyme system
[the acid (proton
H+) pump] in the
parietal cells.
INDICATION
OR PURPOSES
CLIENTS
RESPONSE TO
THE
MEDICATION
Used to treat
INDICATION
partial
onset
OR PURPOSES
seizures
Duodenal and
gastric ulcer.
Gastroesophag
eal reflux
disease
including
severe erosive
esophagitis
Clients response
to medication is
well as evidenced
by controlled pain
86
Nursing Responsibilities
Before:
Observe 10 Rs of administration of drugs '
Check doctors order three times and verify the patient
Check the label of the drug, its name and its expiration date
Wash hands before handling the medication
Assess patients vital signs prior to administering the medication
During:
After:
Observe for the sensitivity and side effects to the drug
Reassess patients level of pain at least 15 and 30 minutes after parenteral
administration
Monitor circulatory and respiratory status and bladder and bowel function.
Caution ambulatory patient about getting out of bed or walking.
87
X. Health Teachings
Medications:
The client was given these medications due to his condition. He was advised
to take Levetiracitam 500mg tab BID.
Levetiracitam 500mg tab BID
Exercise:
Range of motion exercises as tolerated.
Avoid strenuous activities.
Therapy:
None
Health Teachings:
Instructed to have adequate rest periods.
Instructed Deep Breathing exercises.
Maintain Proper Hygiene.
Diet:
Instructed to eat foods low in salt and low in fat.
Increase oral fluids
88